Page 74 - RUFARS 2021 - Proceedings

ISSN: 2659-2029
Proceedings of the 4 Research Symposium of the Faculty of Allied Health Sciences
th
University of Ruhuna, Galle, Sri Lanka
August 26, 2021

PP 14

Awareness and Experience about Government Pharmaceutical Pricing
Regulations on Medication Usage of Patients with Chronic
Non-communicable Diseases

2
Prasadi D.G.P. 1,4# , Dhanarisi H.K.J. , Fahim A.C.M. , Pathiraja V.M.
4
2,3
1 Department of Pharmacy, Faculty of Allied Health Sciences, University of Peradeniya
2 South Asian Toxicology Research Collaboration, Faculty of Medicine, University of
Peradeniya
3 Department of Pharmacy, Faculty of Allied Health Sciences, University of Peradeniya
4 Department of Pharmacy, Faculty of Allied Health Sciences, University of Ruhuna

# Corresponding author: pathmilaguruge30@gmail.com

Background: Different number of brand names are promoted for one generic medication with a
wide price variation in Sri Lanka. Different countries apply varied pricing policies to ensure
price control of medicines. The extraordinary Gazettes were established by Sri Lankan
government to regulate the price of medicines in 2016, 2017, 2018 and 2019 which affected on
price of selected medicines in Sri Lanka.

Objectives: To assess awareness and experience about government pharmaceutical pricing
regulations on medication usage of patients with chronic non-communicable diseases (NCDs).

Methods: The study was a prospective cross-sectional study conducted from November 2019 to
February 2020. Data was obtained from 400 patients with chronic NCDs using an interviewer
administered questionnaire. The questionnaire was content and face validated using 20 patients.
The awareness and experience about government pharmaceutical pricing regulations on
medication usage of patients with chronic non-communicable diseases were assessed from
patients who attended two pharmacies in Peradeniya and Kandy using convenience sampling
method.

Results: Among the 400 patients, 56% were females and median age was 64 years. The most
commonly observed NCD was hypertension (56.75%). Of the total sample, 53% were aware
about price regulations. Out of the patients who were aware about new pharmaceutical revised
pricing policy, 67% of patients were aware about medication price changes as well. Moreover,
86% of patients experienced price increment, 8% experienced a reduction and 6% experienced
no change. Substituted medicines were used by patients due to the perception on effectiveness
(37.88%), price (18.18%) and unavailability (0.76%). Among the patients who were aware
about price regulations, 27% of patients mentioned that it is extremely favorable to Sri Lanka.

Conclusions: Majority of the patients in the selected sample were aware of price regulations of
medicines and patient’s satisfaction was less regarding regulations.

Keywords: Extraordinary Gazette, Generic, Non-communicable diseases, Pharmaceutical
pricing regulation

74